[Hormonal therapy prolongs survival after the irradiation of locally advanced breast carcinomas: a randomized Phase-III study of the European Organization for Research and Treatment of Cancer (EORTC)].
Rauschecker
H F
HF
D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy*; D002277:Carcinoma / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy*; D017024:Chemotherapy, Adjuvant; D017326:Clinical Trials, Phase III as Topic; D005260:Female; D006728:Hormones / Q000627:therapeutic use*; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology; D009367:Neoplasm Staging
D006728:Hormones
Hormontherapie verlängert die Uberlebenszeit nach Bestrahlung lokal fortgeschrittener Mammakarzinome: eine randomisierte Phase-III-Studie der Europäischen Organisation für die Erforshung und Behandlung von Krebserkrankungen (EORTC).